[1] [2] Approved in November 2023, Zepbound represents a novel therapeutic approach for significant weight reduction
The numbers look different from everything they read online
IV hydration and vitamin therapy High-dose vitamin C, NAD+ injections, and immune support IVs support energy, metabolism, and recovery during your weight loss journey
CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors
ApoB, triglycerides, and the lipid panel Weight loss and GLP-1s both improve your lipid panel, and triglycerides move the most, often dropping 20% or more
It doesnt depend on the presence of diabetes that was shown in the SELECT trial and doesnt necessarily depend on obesity. That would require one of the pharmaceutical companies to carry out a clinical trial that would allow drug regulators to further expand the use of these medications